Singapore Cartilage repair is a process that encompasses treatment of
the damaged cartilage through different modalities such as chondroplasty,
autologous chondrocyte implantation, osteochondral allograft, and juvenile
allograft fragments to restore normal functions of the connective tissue.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱
𝐑𝐞𝐩𝐨𝐫𝐭
https://www.alliedmarketresearch.com/cartilage-repair-market
Singapore cartilage repair market is anticipated to grow
considerably in the near future, owing to different factors such as increase in
obesity & sedentary lifestyle among the population, rise in elderly
population, and upsurge in prevalence of arthritis globally. However, high
costs associated with cartilage repair procedures and unclear regulatory
scenario are the key factors that are expected to impede the market growth. On
the contrary, the emerging markets such as India and China are anticipated to
provide lucrative growth opportunities to the market players during the
forecast period.
By modality, chondroplasty & microfracture accounted for
more than one-fourth share of the global cartilage repair market in 2017. In
terms of application, the knee segment garnered nearly half of the market share
in 2017, and is projected to exhibit prominent growth rate, owing to surge in
prevalence of knee osteoarthritis globally.
Among end users, hospitals & clinics generated the
highest revenue in 2017, due to different factors such as availability of
different treatment options (chondroplasty, osteochondral autograft
transplantation, and others) under one roof, palliative care, and diagnosis. By
region, North America was the highest revenue contributor in the global market
in 2017.
North America was the leading revenue contributor to the
global market in 2017, owing to high adoption rate of cartilage repair
products. However, Asia-Pacific is expected to grow at the highest CAGR of
16.5% from 2018 to 2025, due to increase in disposable income; surge in
research, development, & innovation activities; and rise in awareness
towards cartilage repair products.
The report provides an extensive competitive analysis and
profiles of the key market players such as Arthrex, Inc., B. Braun Melsungen
AG, Conmed Corporation, Johnson & Johnson, Osiris Therapeutics, Inc., RTI
Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel
Corporation, and Zimmer Biomet Holdings, Inc. The other players in the value
chain (not included in the report) include Anika Therapeutics, Inc., Collagen
Solutions LLP, and Histogenics Corporation.
0 Comments